Cyprotex PLC ("Cyprotex" or "the Company" or "the Group")
Cyprotex (LSE:CRX), the drug discovery technology and information company, notes yesterday's fall in the share price and is unaware of any reason for this share price movement. The Company re-iterates that its current trading is in line with market expectations following its trading update of 20 November 2009.
The Company expects to release a trading update towards the end of January 2010, in respect of calendar year ended 31 December 2009.
For further information:
Dr Anthony Baxter, Chief Executive Officer
John Dootson, Chief Financial Officer
Tel: +44 (0) 1625 505 100
Noble & Company
Tel: +44 (0) 20 7763 2200
Ben Brewerton / Ben Atwell / John Dineen
Tel: +44 (0) 20 7831 3113